Experience

Davis Polk advised Banco Santander, S.A. in connection with its underwritten rights offering of 1,458,232,745 ordinary shares. The offering raised gross proceeds of approximately €7.07…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75 million initial public offering of common stock of Mersana Therapeutics…

Davis Polk advised Ruby Tuesday, Inc., as borrower, in connection with a senior secured 364-day revolving credit facility in the amount of $20 million, including a $15 million letter of…

Davis Polk advised Banco Santander S.A. in connection with its SEC-registered offering of $1 billion aggregate principal amount of 3.500% second-ranking senior notes due 2022, $1 billion…

Davis Polk advised the dealer managers on a cash tender offer by Discovery Communications, LLC for up to $600 million combined aggregate principal amount of its 5.050% senior notes due 2020…

Davis Polk advised the joint bookrunners and representatives of the several underwriters in connection with an SEC-registered offering of $450 million aggregate principal amount of a new…

Davis Polk advised Auris Medical Holding AG on its $10 million public offering of 10,000,000 of its common shares and 10,000,000 warrants, each warrant entitling its holder to purchase 0.7…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Banco Supervielle S.A. of an aggregate principal amount of approximately ARS 4.8 billion (…

Davis Polk advised Affimed N.V. on its $18 million public offering of 10,000,000 of its common shares. The underwriters have a 30-day option to purchase an additional 1,500,000 shares. The…

Davis Polk advised Banco Santander Chile in connection with its Regulation S offering in Taiwan of $185 million aggregate principal amount of floating-rate notes due 2021.  Banco…